Access to anti-retroviral drugs, male in Tajikistan
Tajikistan: Access to anti-retroviral drugs, male was 72.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Tajikistan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Tajikistan is 72.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 9.1% on the previous year and up 500.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Tajikistan peaked at 72.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Tajikistan 65th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Tajikistan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 3.0% | +50.0% |
| 2010 | 5.0% | +66.7% |
| 2011 | 6.0% | +20.0% |
| 2012 | 7.0% | +16.7% |
| 2013 | 9.0% | +28.6% |
| 2014 | 12.0% | +33.3% |
| 2015 | 18.0% | +50.0% |
| 2016 | 25.0% | +38.9% |
| 2017 | 31.0% | +24.0% |
| 2018 | 38.0% | +22.6% |
| 2019 | 42.0% | +10.5% |
| 2020 | 47.0% | +11.9% |
| 2021 | 53.0% | +12.8% |
| 2022 | 58.0% | +9.4% |
| 2023 | 66.0% | +13.8% |
| 2024 | 72.0% | +9.1% |
Tajikistan compared with similar countries
- Tajikistan's 72.0% is above the median for lower middle income countries, which is 71.0%, 1.0× the median. (39 countries reporting)
- Tajikistan's 72.0% is below the median for Europe & Central Asia, which is 82.0%, 88% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 3.0% | 10 |
| 2010s | 19.3% | 5.0% | 42.0% | 10 |
| 2020s | 59.2% | 47.0% | 72.0% | 5 |
Countries ranked near Tajikistan
More gender data for Tajikistan
- Child population (UN estimates and projections) 3,892 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4634 % change on previous year (2030)
- Population 7,841 (2030)
- Working-age population (UN estimates and projections) 7,841 (2030)
- Population (UN estimates and projections), annual growth rate 2.7 % change on previous year (2030)
- Age population, age 00, female, interpolated 126,845 (2025)
- Age population, age 00, male, interpolated 134,134 (2025)
- Age population, age 01, female, interpolated 127,721 (2025)
- Age population, age 01, male, interpolated 134,916 (2025)
- Age population, age 02, female, interpolated 128,822 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Tajikistan?
- Access to anti-retroviral drugs, male in Tajikistan was 72.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Tajikistan?
- The highest recorded value was 72.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Tajikistan?
- The lowest recorded value was 0.0% in 2000.
- How does Tajikistan rank for access to anti-retroviral drugs, male?
- Tajikistan ranks 65th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Tajikistan?
- Over the last ten years it is up 500.0%. The long-run trend across the full record is volatile.
- Where does this Tajikistan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.